Clinical Trial Update: Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adebrelimab in combination with apatinib and chemotherapy/chemoradiotherapy for immuno-experienced second-line esophageal squa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• Apatinib (apatinib)

Snippet

Sponsor: The First Affiliated Hospital of Henan University of Science and Technology | Conditions: Esophageal Cancer | Phase 2 | Status: NOT_YET_RECRUITING